退出
我的积分:
中文文献批量获取
外文文献批量获取
Tamasree Majumder; Gopa Roy Biswas; Sutapa Biswas Majee;
Department of Pharmaceutical Technology;
NSHM Knowledge Campus-Group of Institutions;
Kolkata 700140;
West Bengal;
India;
羟丙基甲基纤维素; 药物输送; 羟丙甲纤维素; 吸水能力; 药物缓慢释放; HPMC; 聚合物; 控制释放;
机译:光学活性抗真菌唑类。九。 2-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl的另一种合成路线)-4-(4-(2-(2,2,3,3-四氟丙氧基)苯基)-3(2H,4H)-1,2,4-三唑酮及其类似物。
机译:3-Hydroxy-2-methyl-1-phenyi-4-pyridone或3-Hydroxy-2-methyl-1-(4-tolyl)-4-pyridone分光光度法测定微量铱(Ⅳ)
机译:重新确定奥美沙坦酯(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)-methyl-4τ(2-hydroxypropan-2-yl)-2-propyl-l-( -[[2-(2H-1,2,3,4-四唑-5-基)-苯基]苯基甲基)-1H-咪唑-5-羧酸酯,C_(29)H_(30)N_6O_6
机译:Targeted drug delivery with focus ultrasound-induced blood-brain barrier opening Using acoustically-activated nanodroplets
机译:Engineering Multifunctional Mesoporous Silica Nanoparticles for Stimuli-responsive Drug Delivery and Bioimaging =设计多功能介孔二氧化矽奈米粒子--用于刺激反应性药物递送和生物成像
机译:3-Carboxy-4-methyl-5-methyl-5-propyl-2-furanpropionate(CMPF)是血液透析患者的临床相关尿毒症吗?
机译:重新确定奥美沙坦酯(5-methyl-2- oxo-2H-1,3-dioxol-4-yl)-methyl-4-(2-hydroxypropan-2-yl)-2-propyl-1-的结构(-2-(2-(2H-1,2,3,4-四唑-5-基)-苯基苯基甲基)-1H-咪唑-5-羧酸酯,C29H30N6O6
机译:2-methyl-2 - ((1-oxo-3 - ((3,3,4,4,5,5,6,6,7,7,8,8,8)早期鱼类毒性数据草案-tridecafluorooctyl)thio)propyl)amino)-1-propanesulfonic acid and 2-hydroxy-N,N,N-trimethyl-3 - ((3,3,4.4,5,5,6,6,7,7,8) ,8,8-十三氟辛基)硫代)-1-丙胺氯化物。
机译:制备drospirenone(6beta 7beta 15beta 16beta-dimethyl 3-ox o-17alfa-p regn-4-ene 21 17-carbolactone drsp)和7 alpha-(3-hydroxy-1-propyl)-6beta 15beta 16beta- dimethylno-5bet androsta no-3beta 5 17beta-triol(zk 92836)和6 beta 7beta 15beta 16beta beta-dimethylne beta-dimethylne beta-53-hydroxy-3-hydroxy-3-hydroxy-alpha-17beta-android-17beta-triol 17-碳内酯(90965)作为中间工艺产品
机译:2-AMINO-11-(4-Hydroxy-3-MethooxyPhenyl)-4-Methyl-10-OXO-3-CYANO-6,7,8,9,10,11-HEXAGIDROPYRIDO [2',3':4, 5] Thieno [2,3-b] QUINOLINE [2-AMINO-11-(4-Hydroxy-3-MethooxyPhenyl)-4-Methyl-10-OXO-3-CYANO-6,7,8,9,10, 11-己基吡咯烷酮[2',3':4,5]硫杂环丁烷[2,3-b]
机译:甲基酯的结晶形式[9S-(9α,10β,12α)]-5,16-BIS [(乙基)甲基] -2,3,9,10,11,12-己基羟基-10-羟基-9 1-OXO-9,12-EPOXY-1H-DIINDOLO [1,2,3-fg:3',2',1'-kl] PYROLO [3,4-i] [1,6]苯甲重氮-10-羧酸(选项),固体形式的甲基酯[9S-(9α,10β,12α)]-5,16-BIS [(乙基硫代甲基)] -2,3,9,10,11,12-HERO HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO [1,2,3-fg:3',2',1'-kl] PYROLO [3,4-i] [1, 6]苯并重氮杂-1-羧酸(可选)的治疗方法和方法神经退行性疾病帕金森氏病[KRYSTALLYCHESKAYA形式的甲基ЭSTERA[9S-(9α,10β,12α)]-5,16-BIS [(ЭTYLTYO)甲基]- 2,3,9,10,11,12-HEXAGIDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO [1,2,3-fg:3',2', 1'-kl]吡咯[3,4-y] [1,6]苯二氮杂-10-碳酸(选择),固体形式的甲基酯[9S-(9α,10β,12α-B)] [5.16] [(乙氧基)甲基] -2,3,9,10,11,12-己基-10-羟基-9-甲基-1-OXO-9,12-环氧-1H-二吲哚[1,2,3-fg: 3',2',1'-kl]吡咯
抱歉,该期刊暂不可订阅,敬请期待!
目前支持订阅全部北京大学中文核心(2020)期刊目录。